Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Anouk Vervaeck

Awards & Distinctions

8 Results

2017

In-vivo evaluation of apocynin for prevention of Helicobacter pylori-induced gastric carcinogenesis

Tessa HoremansGaëlle BouletMarian van KerckhovenJohannes BogersSofie ThysChris VervaetAnouk VervaeckPeter DelputteLouis MaesPaul Cos

A1 Journal Article in EUROPEAN JOURNAL OF CANCER PREVENTION

Pharmacokinetic analysis of modified-release metoprolol formulations : an interspecies comparison

Elien De ThayeAnouk VervaeckEleonora MarosticaJean Paul RemonJan Van BocxlaerChris VervaetAn Vermeulen

A1 Journal Article in EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

2015

Fatty acids for controlled release applications: a comparison between prilling and solid lipid extrusion as manufacturing techniques

Anouk VervaeckTinne MonteyneFlorence SiepmannMatthieu BooneLuc Van HoorebekeThomas De BeerJürgen SiepmannJean Paul RemonChris Vervaet

A1 Journal Article in EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Prilling of fatty acids as innovative technology for oral controlled release multiple-unit systems

Anouk VervaeckChris VervaetJean Paul Remon

Thermoplastic polyurethanes for the manufacturing of highly dosed oral sustained release matrices via hot melt extrusion and injection molding

Bart ClaeysAnouk VervaeckXander HillewaereSam PossemiersLaurent HansenThomas De BeerJean Paul RemonChris Vervaet

A1 Journal Article in EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

2014

Prilling as manufacturing technique for multiparticulate lipid/PEG fixed-dose combinations

Anouk VervaeckTinne MonteyneLien SaerensThomas De BeerJean Paul RemonChris Vervaet

A1 Journal Article in EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

2013

Prilling of fatty acids as a continuous process for the development of controlled release multiparticulate dosage forms

Anouk VervaeckLien SaerensBruno De GeestThomas De BeerR CarleerP AdriaensensJean Paul RemonChris Vervaet

A1 Journal Article in EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

2012

Poly(2-ethyl-2-oxazoline) as matrix excipient for drug formulation by hot melt extrusion and injection molding

Bart ClaeysAnouk VervaeckChris VervaetJean Paul RemonRichard HoogenboomBruno De Geest

A1 Journal Article in MACROMOLECULAR RAPID COMMUNICATIONS